Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironment
Journal Title
Journal of Clinical Investigation
Publication Type
Dec 30
Abstract
Aged individuals with somatic TP53 mutations manifest clonal hematopoiesis (CH) and are at high risk of developing myeloid neoplasms. However, the underlying mechanisms are not fully understood. Here we show that inflammatory stress confers a competitive advantage to p53 mutant hematopoietic stem and progenitor cells (HSPCs) by activating the NLRP1 inflammasome and increasing the secretion of pro-inflammatory cytokines such as IL-1β, inhibiting wild type (WT) HSPC fitness in a paracrine fashion. During aging, mutant p53 dysregulates pre-mRNA splicing in HSPCs, leading to enhanced NF-κB activation and increased secretion of IL-1β and IL-6, thereby generating a chronic inflammatory bone marrow microenvironment. Furthermore, blocking IL-1β with IL-1β neutralizing antibody or inhibiting IL-1β secretion using gasdermin D (GSDMD) inhibitor decreases the fitness of p53 mutant HSPCs. Thus, our findings uncover an important role for mutant p53 in regulating inflammatory signaling in CH and suggest that curbing inflammation may prevent the progression of TP53-mutant clonal hematopoiesis to myeloid neoplasms.
Publisher
ASCi
Keywords
Cytokines; Hematology; Hematopoietic stem cells; Inflammation; NF-kappaB
Research Division(s)
Inflammation
PubMed ID
41468163
Open Access at Publisher's Site
https://doi.org/10.1172/JCI184285
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-01-22 09:59:55
Last Modified: 2026-01-22 10:03:26
An error has occurred. This application may no longer respond until reloaded. Reload 🗙